HSICHenry Schein
Henry Schein, Inc. is a solutions company for health care professionals powered by a network of people and technology. 10-K, Item 1
- Employees
- 25,000
- Headquarters
- Melville, NY
- CEO
- Stanley M. Bergman
- Next results
- around Feb 23, 2027
41 new paragraphs in the 10-K, 25 new in the latest 10-Q
Paragraphs with nothing like them in last year's 10-K
41 paragraphs in Risk Factors of the 10-K filed Feb 24, 2026 with nothing like them in the 10-K filed Feb 25, 2025. Quoted exactly. Paragraphs that were only edited are under 10-K change.
Compared with the Risk Factors in the latest 10-K of the other 59 Health care companies: a paragraph with at least half its words the same at another company is called similar, and the companies are listed under it. A paragraph most of them have is marked boilerplate. No line means no other company has one like it. This counts text; it does not say how serious a risk is.
product recalls, product detentions, and/or cessation of sales) or an interruption
In the event of any such interruption in supply, we would need to timely identify and obtain acceptable
timely basis, if at all, and an extended interruption in supply, particularly of a high-sales volume and/or high-
margin product, could result in a significant disruption in our sales and operations,
Similar paragraph at 1 of 59 other Health care companies: RMDRead in the 10-K ↗
into an amendment to the Partnership Agreement that increased the beneficial ownership
of the outstanding shares of the Company’s common stock that KKR is permitted to acquire during the
Similar paragraph at 1 of 59 other Health care companies: UHSmonths following the later of the expiration of the term of the Partnership Agreement
exercise the Extension Election (as defined in the Partnership Agreement) whereby
Directors will renominate KKR’s designees, Max Lin and William K. “Dan” Daniel, to stand for election at the
Company’s 2026 annual meeting of stockholders for a term expiring at the Company’s 2027 annual meeting of
have relationships with the Company, or in competitors of such entities, which may create unintended conflicts
Read in the 10-K ↗
potential misdiagnosis or misinformation provided from AI applications, diminishing
protection, privacy, intellectual property, and other laws), regulatory actions, and reputational harm.
capture and summarize patient interactions, and voice-activated perio charting),
Read in the 10-K ↗
could endanger our intellectual property, lead to misuse or loss of data and cause reputational harm and other fines,
Read in the 10-K ↗
personnel with our culture, management policies, legal, regulatory and compliance
Read in the 10-K ↗
Show the other 14
influence on actions requiring a stockholder vote, including the election of directors
Read in the 10-K ↗
health information in our customers’ electronic medical and dental records, certain
Read in the 10-K ↗
and may continue to be, targets to cyberattacks as we update their defensive measures
Read in the 10-K ↗
We utilize security technologies designed to protect and maintain the integrity of our IS and data, and our defenses
incur, and may in the future incur substantial costs as we update our cybersecurity defense systems
A cyberattack that bypasses or compromises our, or our vendors’, IS cybersecurity and/or general
has in the past led, to a disruption of our, or our vendors’, IS business systems (including third-party systems
Any of these impacts may alone, or collectively, have a material impact on our business.
Read in the 10-K ↗
In addition to immaterial and unrelated incidents at certain of our subsidiaries,
Read in the 10-K ↗
We have spent, and plan to expend in the future, additional resources to continue to
protect against, or to address problems caused by, business interruptions and data security breaches.
be perceived as a more vulnerable target of the cyber hackers as a result of the October
Read in the 10-K ↗
been undergoing significant changes driven by various efforts to reduce costs, including, among
in the health care industry, our business could be materially adversely affected.
Similar paragraph at 1 of 59 other Health care companies: IQVinsurance coverage in the United States and has been the target of legal and political
Read in the 10-K ↗
under “Management’s Discussion and Analysis of Financial Condition and Results of Operations, Cautionary
Similar paragraph at 1 of 59 other Health care companies: VRTXRead in the 10-K ↗
The U.S. government and industry trade associations (among others) have expressed
Read in the 10-K ↗
companies, such as us, that are either established in the EU and process personal
Read in the 10-K ↗
This private right of action may increase the likelihood of, and risks associated
January 1, 2026, the CCPA/CPRA regulatory framework includes expanded requirements.
Read in the 10-K ↗
artificial intelligence (the EU AI Act), for example, establishes a comprehensive
Read in the 10-K ↗
Additionally, under the GDPR (and equivalent laws) and U.S. state privacy laws, health data belong to the category
Read in the 10-K ↗
On July 15, 2025, the Company announced that Mr. Bergman will retire as the Company’s CEO on December 31,
2025 (which date was extended to March 1, 2026), and that Mr. Bergman will continue to serve as Chairman of the
transitions among senior level officers can present challenges as well as opportunities,
Read in the 10-K ↗
Paragraphs in the 10-Q filed Nov 3, 2026 that were not in the one before
25 paragraphs in the 10-Q filed Nov 3, 2026 with nothing like them in the 10-Q filed Aug 4, 2026 (at least half the words must differ; new numbers alone do not count). Quoted exactly, grouped by the item heading above them. This is text that changed, not a judgement of how serious it is.
Financial statements and notes
Three Months Ended Nine Months Ended September 26, September 27, September 26, September 27, 2026 2025 2026 2025 Stock options 178,152 393,413 482,975 397,613 Restricted stock units 1,722 4,630 574 4,523 Total anti-dilutive securities excluded from earnings per share computation 179,874 398,043 483,549 402,136
Read in the 10-Q ↗
On October 8, 2026, we announced that, effective November 4, 2026, Ronald N. South will transition from his
Read in the 10-Q ↗
position as Senior Vice President and Chief Financial Officer to the role of Senior Advisor. Emmanuel Caprais,
Read in the 10-Q ↗
Senior Financial Advisor as of October 12, 2026, will succeed Mr. South as Chief Financial Officer effective
Read in the 10-Q ↗
million, respectively, related to previously paid IEEPA tariffs. We expect to recognize additional benefit from
Read in the 10-Q ↗
Show the other 20
Services segment, we recognized a net benefit of $20 million related to refunds for certain IEEPA tariffs previously
Read in the 10-Q ↗
previously paid in the United States. In addition to the benefit of the tariff refunds, the increase in gross margin
Read in the 10-Q ↗
Interest income during the three months ended September 26, 2026 included $2 million of a benefit related to
Read in the 10-Q ↗
refunds of certain IEEPA tariffs previously paid in the United States. Interest expense increased primarily due to
Read in the 10-Q ↗
further impacted by the tax treatment associated with the acquisition of a controlling interest of a previously held
Read in the 10-Q ↗
Nine Months Ended September 26, 2026 Compared to Nine Months Ended September 27, 2025
Read in the 10-Q ↗
Services segment, we recognized a net benefit of $21 million related to refunds for certain IEEPA tariffs previously
Read in the 10-Q ↗
previously paid in the United States. In addition to the benefit of the tariff refunds, the increase in gross margin
Read in the 10-Q ↗
Interest income during the nine months ended September 26, 2026 included $2 million of a benefit related to
Read in the 10-Q ↗
refunds of certain IEEPA tariffs previously paid in the United States. Interest expense increased primarily due to
Read in the 10-Q ↗
further impacted by the tax treatment associated with the acquisition of a controlling interest of a previously held
Read in the 10-Q ↗
Controls and procedures
considered in the aggregate, represents a material change in our internal control over financial reporting.
Read in the 10-Q ↗
Finally, activities related to value creation initiatives and the transition to a global business services model were
Read in the 10-Q ↗
initiated for certain businesses. These activities included current process knowledge transfer from the Company to
Read in the 10-Q ↗
the global business services provider as well as process monitoring by the Company as the global business services
Read in the 10-Q ↗
design and operating effectiveness of our internal control over financial reporting.
Read in the 10-Q ↗
Other information
On July 30, 2026, we announced that, effective October 30, 2026, Mark E. Mlotek, the Company’s Executive Vice
Read in the 10-Q ↗
President and Chief Strategic Officer, would transition out of his current role into a senior advisory role. The
Read in the 10-Q ↗
effective date of Mr. Mlotek’s transition has been extended to December 26, 2026. As previously announced, Mr.
Read in the 10-Q ↗
Item 6
Inc., as seller, the agent, and the various purchaser groups and purchaser agents
Read in the 10-Q ↗
The 10-Q's risk factors against the 10-K
Item 1A of the 10-Q filed Nov 3, 2026 against Item 1A of the 10-K filed Feb 24, 2026.
A 10-Q repeats only the risks that changed, so a 10-K paragraph that is missing from it is not counted as removed.
Added is a paragraph with nothing like it in the 10-K, Reworded a sentence that is in both with several words changed,
Quiet changes a sentence in both where one to four words changed and one is a hedge or a modal
(cut words struck through, new words highlighted and underlined).
Text on the page, not a score; each links to the filing at sec.gov.
What the 10-Q itself says about its risk factors:
Read in the 10-Q ↗
There have been no material changes from the risk factors disclosed in Part I, Item 1A, of our Annual Report on
1 paragraph in the 10-Q's Item 1A, and none of them adds, rewords or quietly edits a paragraph of the 10-K's.
Work on HSIC in a spreadsheet:
Excel workbook (a sheet per section, ten years by column, charts, links to the filings) ·
CSV.
For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/HSIC/export.csv") into a cell.